GB1317027A - Proteins - Google Patents

Proteins

Info

Publication number
GB1317027A
GB1317027A GB2447770A GB2447770A GB1317027A GB 1317027 A GB1317027 A GB 1317027A GB 2447770 A GB2447770 A GB 2447770A GB 2447770 A GB2447770 A GB 2447770A GB 1317027 A GB1317027 A GB 1317027A
Authority
GB
United Kingdom
Prior art keywords
immunizing
inflammatory
microorganism
composition
neissevia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2447770A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of GB1317027A publication Critical patent/GB1317027A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB2447770A 1969-05-20 1970-05-20 Proteins Expired GB1317027A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6916297A FR2043475A1 (zh) 1969-05-20 1969-05-20

Publications (1)

Publication Number Publication Date
GB1317027A true GB1317027A (en) 1973-05-16

Family

ID=9034297

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2447770A Expired GB1317027A (en) 1969-05-20 1970-05-20 Proteins

Country Status (11)

Country Link
BE (1) BE750641A (zh)
CA (1) CA929476A (zh)
CH (1) CH527272A (zh)
DE (1) DE2024586B2 (zh)
DK (1) DK129466B (zh)
ES (1) ES379815A1 (zh)
FR (1) FR2043475A1 (zh)
GB (1) GB1317027A (zh)
HU (1) HU162857B (zh)
NL (2) NL169754C (zh)
SE (1) SE392904B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253499B1 (zh) * 1973-12-10 1977-11-04 Fabre Sa Pierre
FR2407262A1 (fr) * 1977-10-27 1979-05-25 Cassenne Lab Sa Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits
NZ188211A (en) * 1977-10-28 1984-09-28 American Cyanamid Co Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
US4298596A (en) * 1979-03-29 1981-11-03 Burroughs Wellcome Co. Trypanosoma cruzi glycoprotein vaccine for inducing immunity to Chagas' disease
FR2462477A1 (fr) * 1979-07-31 1981-02-13 Cassenne Lab Sa Nouvelles glycoproteines de klebsiella pneumoniae, procede d'obtention, application a titre de medicaments et compositions les renfermant
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
WO1983003354A1 (en) * 1982-03-30 1983-10-13 Us Army Neisseria gonorrhoeae vaccine
FR2574429B1 (fr) * 1984-12-06 1987-12-11 Roussel Uclaf Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4912200A (en) * 1987-05-11 1990-03-27 Schering Corporation Extraction of granulocyte macrophage colony stimulating factor from bacteria
FR2653014B1 (fr) * 1989-10-17 1994-09-16 Roussel Uclaf Utilisation de glycoproteines extraites de bacteries gram (-) pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant.
EP0552571A1 (en) * 1992-01-09 1993-07-28 Becton, Dickinson and Company Release of intracellular components
EP0556521A1 (en) * 1992-01-09 1993-08-25 Becton, Dickinson and Company Sample processing using disinfectant

Also Published As

Publication number Publication date
FR2043475A1 (zh) 1971-02-19
DK129466B (da) 1974-10-14
BE750641A (fr) 1970-11-20
HU162857B (zh) 1973-04-28
NL169754B (nl) 1982-03-16
SE392904B (sv) 1977-04-25
CH527272A (fr) 1972-08-31
DK129466C (zh) 1975-03-10
CA929476A (en) 1973-07-03
DE2024586B2 (de) 1979-06-07
DE2024586C3 (zh) 1980-02-14
NL7007262A (zh) 1970-11-24
NL169754C (nl) 1982-08-16
NL174267B (nl)
DE2024586A1 (de) 1970-11-26
ES379815A1 (es) 1972-09-01

Similar Documents

Publication Publication Date Title
GB1317027A (en) Proteins
AU1198288A (en) Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor
IL109381A0 (en) Processes for the isolation, selection and propagation of animal stem cells, genetically modified animals and animal cells, and vectors for the production thereof
ATE92959T1 (de) Herstellung von chimaeren antikoerpern.
MXPA01004503A (es) Alfa 1,2-fucosiltransferasa de helicobacter pylori.
EP0200909A3 (en) Preparation of protein g and/or fragments thereof
KR880014109A (ko) 암-관련 항원-특이적 인간 면역 글로불린 및 인간 면역 글로불린 을 생산하는 능력을 갖는 인간/인간 하이브리도마
GB1233744A (zh)
GB1387965A (en) Process for the production of the antibiotic cephemycin
GB1358726A (en) Process for the production of polycarbonates
GB1133579A (en) Process for preparing proteases and enzymatic composition prepared thereby
IE39141B1 (en) Production of immunological material
GB1260963A (en) Substituted insulins
ES422433A1 (es) Un procedimiento para la produccion del antibiotico a-287.
GB1387592A (en) Process for preparing an interferon inducer
GB1132019A (en) Urethane coating compositions
BE767940A (fr) Procede de preparation du bouillon de culture de macrochampignons, notamment de champignons alimentaires pour la production de l'inoculant industriel et pour la culture
CA2064774A1 (en) Culture methods for producing activated protein c
GB1493542A (en) Production of thermostable lactose
ES373015A1 (es) Un procedimiento para preparar proteina.
ES317455A1 (es) Procedimiento para la produccion de una vacuna antigena somatica.
GB1343755A (en) Vaccine for dental caries
ES405090A1 (es) Procedimiento para la produccion de acido citrico.
ES409978A1 (es) Metodo para la produccion de antibioticos no nitrogenados acidos.
USD168531S (en) Pen or similar article

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years